Brief: Shattuck Labs reports Q2 results
11/08/2022 11:23
Aug 11 (Reuters) - Shattuck Labs Inc STTK.O :
* NET LOSS WAS $27.4 MILLION FOR THE QUARTER ENDED JUNE 30,
2022,
OR $0.65 PER BASIC AND DILUTED SHARE
* AS OF JUNE 30, 2022, CASH AND CASH EQUIVALENTS AND
SHORT-TERM
INVESTMENTS WERE $214.2 MILLION
* SHATTUCK LABS - BELIEVES CASH AND CASH EQUIVALENTS AND
SHORT-TERM INVESTMENTS WILL BE SUFFICIENT TO FUND ITS OPERATIONS
INTO THE SECOND HALF OF 2024
* Q2 EARNINGS PER SHARE VIEW $-0.59 -- REFINITIV IBES DATA
Source text for Eikon: ID:
Further company coverage: STTK.O
Recent news on Shattuck Labs
See all newsBrief: Shattuck Labs Announces Phase 2 Clinical Trial Of Sl-325 In Hidradenitis Suppurativa And Appointment Of Shoba Ravichandran, M.D., As Senior Vice President, Clinical Development
Shattuck Labs Inc reports results for the quarter ended June 30 - Earnings Summary
U.S. STOCKS ON THE MOVEX-Abbott, Columbia Financial, Jabil
U.S. STOCKS ON THE MOVEX-Abbott, Columbia Financial, Jabil,
U.S. STOCKS ON THE MOVE-Duke Energy, Sea, Cardinal Health